Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
Currency effects weighed on the Swiss drugmaker's first-quarter earnings
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
